Dictasol Mediscript India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 3.00 M
- Satisfied Charges ₹ 4.00 M
About Dictasol Mediscript India
Dictasol Mediscript India Private Limited (DMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 August 2010 and has a history of 14 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sushma Arisetty and Muppidi Kumar serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72300TG2010PTC069887
- Company No.
069887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2010
- Date of AGM
29 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Dictasol Mediscript India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushma Arisetty  | Director | 09-Aug-2010 | Current |
| Muppidi Kumar | Director | 01-Mar-2016 | Current |
Financial Performance of Dictasol Mediscript India.
Enhance accessibility to Dictasol Mediscript India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dictasol Mediscript India?
Unlock access to Dictasol Mediscript India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.00 M
₹4.00 M
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2013 | State Bank Of Hyderabad | ₹3.00 M | Open |
| 09 Feb 2011 | State Bank Of Hyderabad | ₹4.00 M | Satisfied |
How Many Employees Work at Dictasol Mediscript India?
Unlock and access historical data on people associated with Dictasol Mediscript India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dictasol Mediscript India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dictasol Mediscript India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
